Role of matrix metalloproteinase-2 in ethanol-induced invasion by breast cancer cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue SUPPL. 3, 2006, Pages

  Luo, Jia ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chinese Academy of Sciences   (China)

Author keywords

Alcohol; ErbB; Fibroblasts; Metastasis; Oxidative stress; Proteinases; Signal transduction

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; ANTIOXIDANT; DIETHYLDITHIOCARBAMIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR PROMOTER;

ANTIOXIDANT ACTIVITY; BREAST CANCER; BREAST EPITHELIUM; CANCER INVASION; CONCENTRATION RESPONSE; CONFERENCE PAPER; ENZYME ACTIVATION; FIBROBLAST; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; SARCOMA CELL; SYSTEMATIC REVIEW; TUMOR PROMOTION;

EID: 33747590348     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04578.x     Document Type: Conference Paper

References (47)

1. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol. Rev. 1993; 15: 7-16.
2. Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol 2005; 35: 213-25.
3. Longnecker MP, Newcomb PA, Mittendorf R et al. Risk of breast cancer in relation to lifetime alcohol consumption. J. Natl Cancer Inst. 1995; 87: 923-9.
4. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 2143-51.
5. Stoll BA. Alcohol intake and late-stage promotion of breast cancer. Eur. J. Cancer 1999; 35: 1653-8.
6. Vaeth PA, Satariano WA. Alcohol consumption and breast cancer stage at diagnosis. Alcohol Clin. Exp. Res. 1998; 22: 928-34.
7. Weiss HA, Brinton LA, Brogan D et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br. J. Cancer 1996; 73: 1298-305.
8. Aye MM, Ma C, Lin H, Bower KA, Wiggins RC, Luo J. Ethanol-induced in vitro invasion of breast cancer cells: the contribution of MMP-2 by fibroblasts. Int. J. Cancer 2004; 112: 738-46.
9. Fan S, Meng Q, Gao B et al. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res. 2000; 60: 5635-9.
10. Izevbigie EB, Ekunwe SI, Jordan J, Howard CB. Ethanol modulates the growth of human breast cancer cells in vitro. Exp. Biol. Med. (Maywood) 2002; 227: 260-5.
11. Ke Z, Lin H, Fan Z et al. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int. J. Cancer 2006; 119: 8-16.
12. Luo J, Miller MW. Ethanol enhances erbB-mediated migration of human breast cancer cells in culture. Breast Cancer Res. Treat. 2000; 63: 61-9.
13. Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro. Oncogene 2003; 22: 5281-90.
14. Meng Q, Gao B, Goldberg ID, Rosen EM, Fan S. Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem. Biophys. Res. Commun. 2000; 273: 448-53.
15. Singletary K. Ethanol and experimental breast cancer: a review. Alcohol Clin. Exp. Res. 1997; 21: 334-9.
16. Singletary KW, Frey RS, Yan W. Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett. 2001; 165: 131-7.
17. Watabiki T, Okii Y, Tokiyasu T et al. Long-term ethanol consumption in ICR mice causes mammary tumor in females and liver fibrosis in males. Alcohol Clin. Exp. Res. 2000; 24: 117S-22S.
18. Lois M, Brown LA, Moss IM, Roman J, Guidot DM. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am. J. Respir. Crit. Care Med. 1999; 160: 1354-60.
19. Partridge CR, Sampson HW, Forough R. Long-term alcohol consumption increases matrix metalloproteinase-2 activity in rat aorta. Life Sci. 1999; 65: 1395-402.
20. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J. Biol. Chem. 1999; 274: 21 491-4.
21. Nagase H, Meng Q, Malinovskii V et al. Engineering of selective TIMPs. Ann. N.Y. Acad. Sci. 1999; 878: 1-11.
22. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998; 21: 75-80.
23. Mandal M, Mandal A, Das S, Chakraborti T, Sajal C. Clinical implications of matrix metalloproteinases. Mol. Cell. Biochem. 2003; 252: 305-29.
24. Werb Z, Ashkenas J, MacAuley A, Wiesen JF. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz. J. Med. Biol. Res. 1996; 29: 1087-97.
25. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 2001; 13: 534-40.
26. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000; 2: 252-7.
27. Hanemaaijer R, Verheijen JH, Maguire TM et al. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer 2000; 86: 204-7.
28. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-90.
29. Talvensaari-Mattila A, Paakko P, Blanco-Sequeiros G, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. Breast Cancer Res. Treat. 2001; 65: 55-61.
30. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002; 296: 1046-9.
31. Singer CF, Kronsteiner N, Marton E et al. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Treat. 2002; 72: 69-77.
32. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 2002; 62: 283-9.
33. Paterson MC, Dietrich KD, Danyluk J et al. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 1991; 51: 556-67.
34. Lacroix H, Iglehart JD, Skinner MA, Kraus MH. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 1989; 4: 145-51.
35. Tauchi K, Hori S, Itoh H, Osamura RY, Tokuda Y, Tajima T. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma. Virchows Arch. A. Pathol. Anat. Histopathol. 1989; 416: 65-73.
36. Bowers G, Reardon D, Hewitt T et al. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene 2001; 20: 1388-97.
37. Spencer KS, Graus-Porta D, Leng J, Hynes NE, Klemke RL. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J. Cell Biol. 2000; 148: 385-97.
38. Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression. J. Cell Physiol. 2002; 192: 225-33.
39. La Rocca G, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer 2004; 90: 1414-21.
40. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin. Cancer Res. 2004; 10: 7621-8.
41. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res. 2003; 5: 130-5.
42. Camps JL, Chang SM, Hsu TC et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl Acad. Sci. USA 1990; 87: 75-9.
43. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 1999; 189: 300-8.
44. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 1999; 43: S42-51.
45. Qian Y, Luo J, Leonard SS et al. Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesis. J. Biol. Chem. 2003; 278: 16 189-97.
46. Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res. 2004; 64: 7464-72.
47. Yoon SO, Park SJ, Yoon SY, Yun CH, Chung AS. Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J. Biol. Chem. 2002; 277: 30271-82.